Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
- 2021 -
2022
-
2023
-
2024
-
2025
August 2021 - 50 products
L
IP
Bortezomib Zentiva 1.0 mg
126.04
153.50
10 %
Lyophilisate: Bortezomibum 1 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
Bortezomib Zentiva 3.5 mg
372.78
421.85
10 %
Lyophilisate: Bortezomibum 3.5 mg
Helvepharm AG
A / SL / SG
FB
G
L
IP
CI
Etoricoxib Sandoz 30 mg
28
13.99
31.65
10 %
Coated tablets: Etoricoxibum 30 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
Etoricoxib Sandoz 60 mg
7
5.55
15.30
10 %
Coated tablets: Etoricoxibum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
Etoricoxib Sandoz 60 mg
28
22.21
40.60
10 %
Coated tablets: Etoricoxibum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan Amlodipin HCT
Zentiva 20 mg/5 mg/12.5 mg
28
15.93
33.75
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan Amlodipin HCT
Zentiva 20 mg/5 mg/12.5 mg
98
45.47
65.90
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/12.5 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/12.5 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/12.5 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/12.5 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/25 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/5 mg/25 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/25 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin HCT
Zentiva 40 mg/10 mg/25 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Clozapin Viatris 25 mg
50
7.03
16.85
10 %
Tablets: Clozapinum 25 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
CM
Clozapin Viatris 100 mg
50
18.50
36.55
10 %
Tablets: Clozapinum 100 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
L
IP
Melphalan Ideogen 50 mg
57.99
79.50
10 %
Ideogen AG
A / SL / SG
FB
G
L
IP
CI
Menopur Multidose Pen 600 IU
160.72
191.20
10 %
Injektionslösung im Fertigpen: Menotropinum 600U.I. / 0.96ml
Ferring AG
A / SL
FB
G
IP
CI
Hepaxane 2000 IE/UI (20
mg)/0.2 ml
10
15.04
32.75
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 20 mg
Effik SA
B / SL
FB
G
L
IP
CI
Hepaxane 2000 IE/UI (20
mg)/0.2 ml
50
75.22
98.20
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 20 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 4000 IE/UI (40
mg)/0.4 ml
2
5.60
15.30
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 4000 IE/UI (40
mg)/0.4 ml
10
28.14
47.00
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg
Effik SA
B / SL
FB
G
L
IP
Hepaxane 4000 IE/UI (40
mg)/0.4 ml
50
140.69
169.40
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 6000 IE/UI (60
mg)/0.6 ml
10
36.79
56.45
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 60 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 8000 IE/UI (80
mg)/0.8 ml
10
52.47
73.50
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 80 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 10'000 IE/UI
(100 mg)/1 ml
10
65.57
87.75
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 100 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 12'000 IE/UI
(120 mg)/0.8 ml
10
72.38
95.15
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 120 mg
Effik SA
B / SL
FB
G
IP
Hepaxane 15'000 IE/UI
(150 mg)/1 ml
10
88.51
112.70
10 %
solution injectable en seringue préremplie: Enoxaparinum Natricum 150 mg
Effik SA
B / SL
FB
G
IP
CI
Abecma
Infusionsdispersion
PR
PR
k.A.
Bristol-Myers Squibb SA
A
FB
G
IP
CI
Tecartus
PR
PR
k.A.
Gilead Sciences
Switzerland Sàrl
A
FB
G
IP
CI
CM
Xylo Zentiva Nasenspray
0.05%
10 ml
PR
PR
k.A.
Nasal spray: Xylometazolini Hydrochloridum
Helvepharm AG
D
FB
G
IP
CM
Xylo Zentiva Nasenspray
0.1%
10 ml
PR
PR
k.A.
Nasal spray: Xylometazolini Hydrochloridum 1 mg/ml/ml
Helvepharm AG
D
FB
G
IP
CI
Slinda 4.0 mg
28
PR
PR
k.A.
Coated tablets: Drospirenonum 4 mg
Exeltis Suisse SA
B
FB
G
IP
CI
Slinda 4.0 mg
3 x 28
PR
PR
k.A.
Coated tablets: Drospirenonum 4 mg
Exeltis Suisse SA
B
FB
G
IP
CI
Slinda 4.0 mg
6 x 28
PR
PR
k.A.
Coated tablets: Drospirenonum 4 mg
Exeltis Suisse SA
B
FB
G
IP
CI
Slinda 4.0 mg
13 x 28
PR
PR
k.A.
Coated tablets: Drospirenonum 4 mg
Exeltis Suisse SA
B
FB
G
IP
CI
Gavreto 100 mg
120
5969.33
6432.35
k.A.
Capsules: Pralsetinibum 100 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Biotin Merz 10 mg
30
PR
PR
k.A.
Tablets: Biotinum 10 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Biotin Merz 10 mg
90
PR
PR
k.A.
Tablets: Biotinum 10 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Flector Dolo Liquid Caps
12.5 mg
10
PR
PR
k.A.
Soft capsules: Diclofenacum Epolaminum 15.38 mg
IBSA Institut
Biochimique SA
D
FB
G
IP
CI
Flector Dolo Liquid Caps
12.5 mg
20
PR
PR
k.A.
Soft capsules: Diclofenacum Epolaminum 15.38 mg
IBSA Institut
Biochimique SA
D
FB
G
IP
CI
Flector Dolo Forte Liquid
Caps 25 mg
10
PR
PR
k.A.
Soft capsules: Diclofenacum Epolaminum 30.76 mg
IBSA Institut
Biochimique SA
D
FB
G
IP
NanoHSA-ROTOP 0.5
5
PR
PR
k.A.
Marker kit: Albuminum Humanum Colloidale
medeo AG
A
FB
G
IP
Menopur Multidose Pen
1200 IU
PR
PR
k.A.
Injektionslösung im Fertigpen: Menotropinum 1200U.I. / 1.92ml
Ferring AG
A
FB
G
CI
Gemmo Schlaf & Beruhigung
30 ml
PR
PR
k.A.
Spray zur Anwendung in der Mundhöhle: Tilia Tomentosa e Gemma Recenti D1 (Ph.Eur.Hom. 2.1.3) 1 ml
Spagyros AG
D
FB
G
IP
CI
Hepaxane 2000 IE/UI (20
mg)/0.2 ml
20
PR
PR
k.A.
solution injectable en seringue préremplie: Enoxaparinum Natricum 20 mg
Effik SA
B
FB
G
IP
Hepaxane 4000 IE/UI (40
mg)/0.4 ml
6
PR
PR
k.A.
solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg
Effik SA
B
FB
G
IP
Hepaxane 4000 IE/UI (40
mg)/0.4 ml
20
PR
PR
k.A.
solution injectable en seringue préremplie: Enoxaparinum Natricum 40 mg
Effik SA
B
FB
G
IP
Hepaxane 6000 IE/UI (60
mg)/0.6 ml
20
PR
PR
k.A.
solution injectable en seringue préremplie: Enoxaparinum Natricum 60 mg
Effik SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home